Product Claims Substantiation Review

What substantiation means in advertising law

Under FTC law, advertisers must have a reasonable basis for objective claims before those claims are disseminated. The level of evidence required depends on the type of claim — health and safety claims typically demand competent and reliable scientific evidence. Subjective puffery ("best-tasting") and obvious exaggeration may not require the same documentation, but implied claims matter: if consumers would understand a statement as a factual promise, substantiation may be required.

For FDA-regulated products, substantiation overlaps with claim category. A structure/function statement for a dietary supplement must be truthful, not misleading, and substantiated, and the brand must notify the FDA and include a standard disclaimer. Disease claims trigger drug regulation regardless of how much evidence exists unless the product is an approved drug.

Brands sometimes assume that because an ingredient is "well studied," any claim about the finished product is automatically supportable. Regulators and courts look at whether the specific claim matches the specific evidence — including population studied, dosage, duration, outcome measures, and product formulation. Bridging studies and extrapolation require careful analysis.

Types of claims that commonly need documentation

• Clinical or quantified results ("clinically shown to reduce wrinkles by 30%")
• Comparative claims against named or identifiable competitors
• Health benefit claims for foods, supplements, and cosmetics
• Performance claims for devices, topicals, and wellness products
• Ingredient-specific mechanism claims ("boosts collagen production")
• Endorsements and testimonials presenting atypical results as typical

FTC substantiation standards

The FTC evaluates whether advertisers possessed substantiation at the time a claim was made — not whether they gathered evidence afterward. Health claims generally require well-controlled human clinical studies when experts in the field would expect that level of proof. The FTC's Health Products Compliance Guidance discusses how the agency applies substantiation principles to health-related advertising.

FDA claim boundaries

Even well-substantiated science may not save a claim if the claim type is impermissible for the product. Supplement brands cannot market products as treatments for diseases without drug approval. Cosmetic brands must avoid drug claims unless the product is approved as a drug. Understanding claim category is as important as understanding the underlying studies. The FDA publishes guidance on distinguishing structure/function statements from disease claims in supplement marketing.

How a substantiation review works

Natascia Taken, Esq. reviews your proposed claims alongside available support materials — clinical studies, literature reviews, consumer perception tests, and ingredient dossiers. The analysis identifies gaps between what marketing says and what evidence reasonably supports, and flags claims that may require a different product regulatory pathway entirely.

Where evidence is thin, options may include narrowing claim language, adding qualifiers, removing comparative elements, or planning additional research. These are strategic business decisions; legal review illuminates risk but does not conduct scientific testing or guarantee any particular regulatory outcome.

Maintaining a substantiation file

Regulators and plaintiffs may request substantiation long after a campaign ends. Organizing studies, expert analyses, and claim-to-evidence mapping at launch makes response faster and demonstrates good-faith compliance efforts. A substantiation file should tie each objective claim in market materials to the specific evidence relied upon at the time of dissemination.

Red flags that often trigger scrutiny

• Claims referencing specific diseases, conditions, or symptoms in supplement or cosmetic ads
• Before-and-after imagery implying measurable clinical outcomes without study support
• "Clinically proven" or "doctor recommended" language without adequate backing
• Cherry-picked statistics from studies that do not match the advertised product or use
• Implied FDA approval or government endorsement through logos or phrasing

Natascia Taken, Esq. helps brands distinguish between claims that may be supportable with existing evidence, claims that need softened language, and claims that require a fundamentally different regulatory strategy. None of this constitutes a guarantee of regulatory acceptance.